Anti-breast cancer of some novel pyrrole and pyrrolopyrimidine derivatives bearing a biologically active sulfonamide moiety

Life Science Journal

Volumn 10, Issue 4, 2013, Pages 2170-2183

  Ghorab, Mostafa M ^a   Alsaid, Mansour S ^a   Nissan, Yassin M ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Anticancer activity; Pyrrole; Pyrrolopyrimidine and sulfonamides

Indexed keywords

EID: 84888795055     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Almann E, Wilder L, Missbach M (2002). Chem. Rev. 2, 208-210
2. Bridges A J (1998). Emerging. Drugs. 3. 279-292
3. Calderwood D J, Johnston D N, Munschauer R. et al (2002). Bioorg. Med. Chem. Lett. 12. 1683-1686
4. Casini A, Scozzafava A, Mastrolorenzo A. et al (2002). Curr. Cancer. Drug. Targets. 2. 55-75
5. Danchev N, Bijev A, Yaneva D. et al (2006). Arch. Pharm. (Weinheim). 339. 670-674
6. Dang J, Gomez-Galeno E (2002). J. Org. Chem. 67. 8703-8705
7. De Clercq E, Balzarini., Madej D. et al (1987). J. Med. Chem. 30. 481-486
8. Esteve C, Nueda A, Diaz J. L. et al (2006). Bioorg. Med. Chem. Lett. 16, 3642-3645
9. Finch R A, Revankar G., Chan P K (1997Anticancer. Drug. Des. 12. 205-215
10. Gangjee A, Jain H D, Kisliuk R L (2005). Bioorg. Med. Chem. Lett. 15, 2225-2230
11. Germ J L, Chabner B A, Colins J M (1990). Lippincot. Pheladelphia. 180-224
12. Ghorab M M, Noaman E, Ismail M M. et al (2006). Arzneimitt-elforschung. 56(6). 405-13
13. Hildick B G, Shaw G (1971). J. Chem. Soc. Perkin 1. 9. 1610-1613
14. Jarvis M F, Yu H, McGaraughty S. et al (2002). Pain. 96. 107-118
15. Kitagawa M, Okabe T, Ogino H. et al (1993). Oncogene. 8. 2425-2432
16. Krawczyk S H, M. Nassiri R, Kucera L. S. et al (1995). J. Med. Chem. 38. 4106-4114
17. MacMahon G, Liang C, Tang C (1998). Cuur. Opin. Drug. Discov. Dev. 1. 131-146
18. Merighi S, Mirandola P, Varani K. et al (2003). Pharmacol Ther. 100. 31-48
19. Morgan D O, Fisher R P, Espinoza F H. et al (1998). Cancer. J. Sci. Am. 77-83
20. Owa T, Yoshino H, Yoshimatsu K. et al (1999). J. Med. Chem, 42. 3798-3799
21. Rostom S. A (2006). Bioorg. Med. Chem. 14. 6475-6485
22. Schilsky R L, Perry M C (1990). The chemotherapy source book, Baltimore, 301-315
23. Showalter H D, Kraker A J (1997). Pharmacol. Ther. 76. 55-71
24. Skehan P, Storeng R, Scudiero D. et al (1990). J. Natl. Cancer. Inst. 82. 1107-1112
25. Strawn L M, Shawver L K (1998). Expert. Opin. Investig. Drugs. 7, 553-573
26. Traxler P, Bold G, Buchdunger E. et al (2001). Med. Res. Rev. 6. 499-512
27. Traxler P (1998). Expert. Opin. Ther. Pat 8. 1599-1625
28. Traxler P M, Furet P, Mett H. et al. (1996). J. Med. Chem. 39. 2285-2292.